Loading
Loading
Regenerative & Anti-Aging · 100mg
Janoshik-tested · 10 vials per kit
AHK-Cu is a tripeptide-copper complex studied in preclinical research for its antioxidant, anti-inflammatory, and skin-regenerative properties. Research has examined its potential to regulate copper ion metabolism, promote collagen synthesis, improve skin aging, accelerate wound healing, enhance skin elasticity, and regulate gene expression. Studies have explored applications in anti-aging dermatology and tissue repair.
≥98%
Purity
Lyophilised
Format
2–3 wks
Arrival
Don't want to wait 3 weeks?
Check local stock — weekday same/next-day delivery available.
Need to work out your dose?
Use our reconstitution calculator — syringe units in seconds.
Research Use Only — Disclaimer
This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.
AHK-Cu
Ala-His-Lys Copper Complex
AHK-Cu (Ala-His-Lys : copper 2+) is a tripeptide copper complex found naturally in human blood plasma, structurally related to GHK-Cu but with a distinct sequence and specialised activity profile. While GHK-Cu (Gly-His-Lys) is widely studied for skin rejuvenation and wound healing, AHK-Cu exhibits particularly pronounced activity in hair follicle biology and androgenetic alopecia research.
AHK-Cu upregulates vascular endothelial growth factor (VEGF) and β-catenin/Wnt signalling in dermal papilla cells — both critical for the anagen (active growth) phase of the hair cycle. The copper component enables lysyl oxidase activity (collagen and elastin crosslinking) shared with GHK-Cu. AHK-Cu has also demonstrated anti-androgenic activity at the hair follicle level, potentially inhibiting dihydrotestosterone (DHT) binding to androgen receptors in dermal papilla cells, which may counter DHT-mediated follicular miniaturisation.
Hair follicle stimulation, androgenetic alopecia research, collagen and elastin synthesis, dermal papilla cell biology, skin rejuvenation. In vitro studies show AHK-Cu outperforms GHK-Cu in hair follicle upregulation assays while sharing the broader collagen and wound healing profile. Research continues into topical and scalp delivery formulations.
For research reference only. All information pertains to preclinical or published human trial data. Not intended as medical advice. This product is for research use only.
Don't have supplies? Grab them while you're here.
